Fidelity Select Biotechnology (FBIOX)
145.60
0.75(0.51%) May 22
| Prev Close: | 146.35 |
|---|
| YTD Return*: | 9.56% |
|---|
| Net Assets*: | 3.45B |
|---|
| Yield*: | N/A |
|---|
* As of 28-Feb-13
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Analysis: Drugmakers face more scrutiny of discordant U.S. pricesReuters(Fri, May 10)
- Top 5 Zacks #1 Ranked Fidelity Mutual FundsZacks(Tue, Apr 23)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Thu, Jan 24)
- Top 5 Zacks #1 Ranked Healthcare Mutual FundsZacks(Wed, Jan 2)
- The Best and Worst Investments of 2012BusinessWeek(Thu, Dec 20)
- Top 5 Zacks #1 Ranked Healthcare Mutual FundsZacks(Fri, Nov 23)
- Learn To Drive Your Own 401kat Forbes(Sat, Oct 20)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Oct 17)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Sep 5)
- Is Your 401(k) Ignoring These Hot Sectors?at TheStreet(Thu, Aug 23)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Aug 1)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Jun 13)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, May 2)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Mar 21)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Mar 21)
Fund Basics
| Morningstar Overall Rating: | |
| Total Assets: | 3.45B |
| Category: | Health |
|---|
| Annual Report Expense Ratio (net): | 0.83% |
|---|
Performance & Risk
| YTD Return: | 9.56% |
| 5y Avg Return: | 15.57% |
| Rank in Category (ytd): | 30 |
| % Rank in Category (ytd): | 21.43% |
| Beta (3y): | 0.88 |
| Morningstar Risk Rating: | 4 |
Fund Summary
The investment seeks capital appreciation.
The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.
View More